The ACC/AHA Task Force on Practice Guidelines was formed to make recommendations
regarding the diagnosis and treatment of patients with known or suspected cardiovascular …

(CAD). Hypertension is a major independent risk factor for the development of CAD, stroke,
and renal failure. The optimal choice of antihypertensive agents remains controversial, and …

Recommendations about therapy for hypertension are here preceded by some
considerations on the strength of available evidence on the benefits associated with …

Task Forces, expert groups, or consensus panels. The chosen experts in these writing
panels are asked to provide disclosure statements of all relationships they may have, which …

For many years, β-adrenergic receptor antagonists (β-blockers or βAR antagonists) have
provided significant morbidity and mortality benefits in patients who have sustained acute …

Objectives: The aim of this multicenter study was to evaluate the prognostic impact of a
therapeutic strategy using plasma brain natriuretic peptide (BNP) levels. Background: The …

ContextAlthough β-blockers improve symptoms and survival in adults with heart failure, little
is known about these medications in children and adolescents. ObjectiveTo prospectively …

BACKGROUND: Diabetes, a common comorbidity in patients with heart failure (HF), is
associated with worse long-term outcomes in patients with HF due to systolic dysfunction …

Oxidative and inflammatory stresses are cardinal in the pathogenesis of hypertension and
atherosclerosis. Oxidative stress also leads to the induction of inflammation through the …

Background: β Blocker treatment may worsen glucose metabolism. Objective: To study the
development of new onset diabetes in a large cohort of patients with heart failure treated …